Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ABBOTT LABORATORIES Stock Hits Forecast Price Target with 10.61% Profit

January 27, 2025
On February 27, 2024, QuantWave, an automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock when it was trading at 116.48 $. Fast forward to January 27, 2025, and the stock reached the predicted target price of 128.83 $, delivering a profit of 10.61% to investors who followed the forecast. This successful prediction showcases the accuracy and reliability of QuantWave's analytics in identifying profitable trading opportunities for its users.

The achievement of the price target for ABBOTT LABORATORIES stock can be attributed to various factors influencing the market, including positive earnings reports, successful product launches, and overall strength in the healthcare sector. Investors who capitalized on this forecast were able to capitalize on the stock's upward momentum and generate significant returns on their investment.

QuantWave's forecasting platform provides users with access to predictions for a wide range of stocks, offering opportunities to potentially profit from market movements. For investors seeking to deepen their understanding of QuantWave's investment strategy, QuantSchool offers comprehensive educational resources that outline the key principles for generating consistent income using the QuantWave forecasting system.

Overall, the successful achievement of the price target for ABBOTT LABORATORIES stock underscores the effectiveness of QuantWave's analytics in identifying profitable trading opportunities in the stock market.
If you want to leave a comment, then you need Login or Register





Other data for ABT

Related data

ABTAugust 9, 2025Abbott Laboratories NYSE:ABT Earnings Are Of Questionable Quality  ~1 min.

Abbott Laboratories recently reported their second quarter 2025 earnings, with EPS exceeding expectations....


ABTJune 5, 2025Abbott Laboratories ABT is Attracting Investor Attention: Here is What You Should Know  ~1 min.

Abbott Laboratories (ABT) has been making waves in the healthcare sector, attracting attention from investors around the globe....


ABTMarch 18, 2025Abbott Laboratories Continues to Drive Growth in the Healthcare Sector  ~2 min.

Abbott Laboratories (ABT) has emerged as a top player in the healthcare industry, making it an attractive stock for long-term investors....


ABTMarch 17, 2025Abbott Laboratories: A Leader in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) is a renowned healthcare company that has caught the attention of investors and industry experts alike....


ABTMarch 16, 2025Abbott Laboratories: Breaking New Ground in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making waves in the healthcare industry with its groundbreaking innovations....


ABTMarch 15, 2025Abbott Laboratories: A Healthcare Stock With Long-Term Investment Potential  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned healthcare company that has been delivering groundbreaking medical technologies and products for decades....


ABTFebruary 26, 2025Abbott Laboratories Continues to Deliver Strong Earnings Growth  ~2 min.

Abbott Laboratories, a leading global healthcare company, has reported steady growth in earnings over the past five years....


ABTFebruary 22, 2025Abbott Laboratories: A Rising Star in the Pharmaceutical Industry  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making significant progress in the pharmaceutical industry, positioning itself as one of the best drug stocks to buy now....


ABTFebruary 21, 2025Abbott Laboratories NYSE:ABT: A Leading Drug Stock with Promising Future  ~1 min.

Abbott Laboratories, a renowned pharmaceutical company, has emerged as one of the best drug stocks to invest in....


ABTFebruary 21, 2025ABBOTT LABORATORIES Stock Hits Price Target with 16.11% Profit: QuantWave Forecast Success  ~2 min.

On December 2, 2024, QuantWave, the automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock when it was trading at 115.66 $....


ABTFebruary 20, 2025ABBOTT LABORATORIES Stock Hits Price Target Forecast with 15.12% Profit, QuantWave Analysis Shows Strong Predictive Power  ~2 min.

ABBOTT LABORATORIES (NYSE: ABT) investors reaped substantial gains as the stock price hit the forecasted target of 132.56 $ on February 20, 2025, resulting in a profit of 15.12%....


ABTOctober 12, 2023ABBOTT LABORATORIES Hits Forecast Price Target with 10.91% Profit, Confirming QuantWave's Accuracy  ~2 min.

Abbott Laboratories (NYSE: ABT) recently achieved the forecast price target set by QuantWave, signaling a profitable short position for investors....


ABTJanuary 27, 2025ABBOTT LABORATORIES Hits Price Target Forecast with 12.05% Profit  ~1 min.

On October 22, 2024, QuantWave issued a price target forecast signal for ABBOTT LABORATORIES with a price of $114.47 and a predicted direction of long....


ABTJanuary 24, 2025ABBOTT LABORATORIES Stock Hits Price Target Forecast with 16.83% Profit  ~1 min.

Abbott Laboratories stock has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 16.83%. The forecast signal was issued on May 4, 2023, with the stock priced at $106....


ABTJanuary 27, 2025ABBOTT LABORATORIES Stock Hits Forecast Price Target with 10.51% Profit Margin  ~1 min.

ABBOTT LABORATORIES stock successfully reached the forecast price target on January 27, 2025, with a profit margin of 10.51%....